SE7505439L - Forfarande for framstellning av 3-(5-nitroimidazol-2-yl)-pyrazolo 3,4-d -pyrimidinforeningar. - Google Patents

Forfarande for framstellning av 3-(5-nitroimidazol-2-yl)-pyrazolo 3,4-d -pyrimidinforeningar.

Info

Publication number
SE7505439L
SE7505439L SE7505439A SE7505439A SE7505439L SE 7505439 L SE7505439 L SE 7505439L SE 7505439 A SE7505439 A SE 7505439A SE 7505439 A SE7505439 A SE 7505439A SE 7505439 L SE7505439 L SE 7505439L
Authority
SE
Sweden
Prior art keywords
nitroimidazol
pyrazolo
procedure
preparation
pyrimidine compounds
Prior art date
Application number
SE7505439A
Other languages
English (en)
Swedish (sv)
Inventor
H Friedman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7505439L publication Critical patent/SE7505439L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7505439A 1974-05-13 1975-05-12 Forfarande for framstellning av 3-(5-nitroimidazol-2-yl)-pyrazolo 3,4-d -pyrimidinforeningar. SE7505439L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46925674A 1974-05-13 1974-05-13
US05/545,852 US4001230A (en) 1974-05-13 1975-01-31 3-(5-Nitroimidazol-2-yl)pyrazolo[3,4-d]pyrimidine compounds

Publications (1)

Publication Number Publication Date
SE7505439L true SE7505439L (sv) 1975-11-14

Family

ID=27042704

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7505439A SE7505439L (sv) 1974-05-13 1975-05-12 Forfarande for framstellning av 3-(5-nitroimidazol-2-yl)-pyrazolo 3,4-d -pyrimidinforeningar.

Country Status (14)

Country Link
US (1) US4001230A (cs)
JP (1) JPS511492A (cs)
AR (2) AR205234A1 (cs)
AU (1) AU8102575A (cs)
BR (1) BR7502919A (cs)
DD (1) DD120442A5 (cs)
DE (1) DE2521046A1 (cs)
DK (1) DK207675A (cs)
ES (1) ES437599A1 (cs)
FR (1) FR2270880A1 (cs)
IL (1) IL47259A0 (cs)
NL (1) NL7505520A (cs)
PH (1) PH11588A (cs)
SE (1) SE7505439L (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075222A (en) * 1975-03-14 1978-02-21 Eli Lilly And Company 3-(5-Nitro-2-imidazolyl)pyrazoles
DE2827351A1 (de) * 1978-06-22 1980-01-10 Basf Ag 2-substituierte 1-alykl-nitroimidazole und verfahren zur herstellung von 2-substituierten 1-alkyl-nitroimidazolen
DE4129488A1 (de) * 1991-09-05 1993-03-11 Vaw Ver Aluminium Werke Ag Verfahren zur ueberfuehrung von schadstoffbelasteten rueckstaenden aus verbrennungsanlagen in eine feste, unbedenklich deponierbare form
US20030199525A1 (en) * 2002-03-21 2003-10-23 Hirst Gavin C. Kinase inhibitors
GB0610242D0 (en) 2006-05-23 2006-07-05 Novartis Ag Organic compounds
US20110224223A1 (en) 2008-07-08 2011-09-15 The Regents Of The University Of California, A California Corporation MTOR Modulators and Uses Thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128809C (cs) * 1966-06-18
BE758050A (fr) * 1969-10-28 1971-04-27 Geigy Ag J R Derives 5-nitro-furyliques et medicaments contenant de tels composes
AR205429A1 (es) * 1971-04-27 1976-05-07 Ciba Geigy Ag Procedimiento para la elaboracion de nuevos derivados de 4-amino - 3-(5-nitro- 2 -furil)-1-metil - 1h - pirazol-(3,4-ol)-pirimidina
PL84022B1 (cs) * 1972-04-01 1976-02-28

Also Published As

Publication number Publication date
PH11588A (en) 1978-03-31
US4001230A (en) 1977-01-04
ES437599A1 (es) 1977-01-16
NL7505520A (nl) 1975-11-17
AR204665A1 (es) 1976-02-20
DK207675A (da) 1975-11-14
DD120442A5 (cs) 1976-06-12
DE2521046A1 (de) 1975-11-27
AU8102575A (en) 1976-11-11
AR205234A1 (es) 1976-04-12
IL47259A0 (en) 1975-12-31
FR2270880A1 (cs) 1975-12-12
JPS511492A (en) 1976-01-08
BR7502919A (pt) 1976-03-23

Similar Documents

Publication Publication Date Title
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE7503689L (sv) Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
NO153806C (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin.
SE409864B (sv) Forfarande for framstellning av 4-imino-1,3-diazabicyklo(3.1.0)hexan-2-on
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
SE7505439L (sv) Forfarande for framstellning av 3-(5-nitroimidazol-2-yl)-pyrazolo 3,4-d -pyrimidinforeningar.
SE428015B (sv) Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat
SE399895B (sv) Forfarande for framstellning av s-triazolo(3,4-b)benstiazoler
SE420603B (sv) Forfarande for framstellning av metyl-3-(2-kinoxolinylmetylen)-karbazat-n?721, n?724-dioxid
SE7601605L (sv) Forfarande for framstellning av 1 alfa,25-dihydroxi-cholkalciferol
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE407219B (sv) Forfarande for framstellning av metyl-3-(2--kinoxalinylmetylen)-karbazat-nŸ1,nŸ4-dioxid
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
NO139684C (no) Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid
SE7507482L (sv) Forfarande for framstellning av substituerade l-sulfonylbensimidazoler.
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7504114L (sv) Forfarande for framstellning av vermherdande fenolformaldehydhartser.
SE7508844L (sv) Forfarande for framstellning av cefalosporiner.
SE426588B (sv) Forfarande for framstellning av aromatiska uretaner.
SE431337B (sv) Forfarande for framstellning av cefalosporinforeningar.
SE386144B (sv) Forfarande for framstellning av en alkaliamid.
NO141512C (no) Fremgangsmaate for fremstilling av alfa-diol- gamma-diokso-forbindelser.